tiprankstipranks
Trending News
More News >
Advertisement

GSEU - ETF AI Analysis

Compare

Top Page

GSEU

Goldman Sachs ActiveBeta Europe Equity ETF (GSEU)

Rating:63Neutral
Price Target:
The Goldman Sachs ActiveBeta Europe Equity ETF (GSEU) has a solid overall rating, driven by strong contributions from holdings like Novartis AG and AstraZeneca. Novartis stands out for its robust profitability, stable balance sheet, and growth in key products, while AstraZeneca benefits from strategic expansions and product approvals. However, holdings such as SAP SE and Allianz, which face bearish momentum and valuation concerns, may have slightly weighed on the fund's performance. A key risk factor is the ETF's exposure to potential overvaluation in some of its top holdings.
Positive Factors
Strong Top Holdings
Several key holdings, such as ASML Holding NV and Nestlé SA, have shown strong year-to-date performance, supporting the ETF's overall returns.
Low Expense Ratio
The ETF has a competitive expense ratio of 0.25%, making it cost-effective compared to many actively managed funds.
Broad Geographic Exposure
The fund invests across multiple European countries, reducing reliance on any single economy.
Negative Factors
Underperforming Holdings
Some top holdings, such as SAP SE, have lagged in performance, which could weigh on future returns.
Sector Concentration in Financials
With over 22% of the portfolio in the financial sector, the ETF is heavily exposed to sector-specific risks.
Limited U.S. Exposure
The ETF has minimal exposure to U.S. companies, which could limit diversification in a global context.

GSEU vs. SPDR S&P 500 ETF (SPY)

GSEU Summary

The Goldman Sachs ActiveBeta Europe Equity ETF (GSEU) is an investment fund that focuses on European companies across various industries and sizes, from large corporations to smaller businesses. It uses a strategy that balances factors like value, momentum, and quality to adapt to market changes. Some well-known companies in the fund include Nestlé and AstraZeneca. Investors might consider GSEU for diversification, as it provides exposure to many sectors and countries in Europe. However, since it is tied to European markets, its performance can be affected by economic or political changes in the region.
How much will it cost me?The Goldman Sachs ActiveBeta Europe Equity ETF (Ticker: GSEU) has an expense ratio of 0.25%, meaning you’ll pay $2.50 per year for every $1,000 invested. This cost is lower than average for actively managed funds because it uses a systematic strategy to balance multiple factors, making it more efficient than many traditional active funds.
What would affect this ETF?The GSEU ETF, which focuses on European equities, could benefit from economic recovery in Europe, increased demand for healthcare and technology innovations, and stable financial sector performance, given its significant exposure to these areas. However, it may face challenges from rising interest rates, regulatory changes in Europe, or economic slowdowns that could negatively impact industrial and consumer sectors. Its diversified holdings across developed European markets provide some resilience against sector-specific risks.

GSEU Top 10 Holdings

The Goldman Sachs ActiveBeta Europe Equity ETF is leaning heavily on healthcare and financial stocks to drive performance, with names like Roche and HSBC showing steady gains thanks to strong earnings and strategic initiatives. Banco Santander has been a standout, rising sharply on robust capital management, while SAP is lagging, weighed down by bearish momentum and valuation concerns. The fund’s European focus is evident, with a mix of developed-market giants across sectors, though healthcare and financials dominate the narrative. Overall, the ETF’s positioning reflects a balanced yet sector-heavy approach to capturing European growth.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV3.05%$3.61M€413.15B48.58%
76
Outperform
Roche Holding AG2.04%$2.42MCHF272.24B45.48%
73
Outperform
Novartis AG1.89%$2.23MCHF217.04B25.19%
80
Outperform
AstraZeneca1.81%$2.14M£220.41B29.45%
80
Outperform
HSBC Holdings1.65%$1.96M£205.11B49.44%
80
Outperform
SAP SE1.56%$1.85M€241.78B-14.21%
66
Neutral
Banco Santander1.36%$1.61M€150.44B133.64%
73
Outperform
Nestlé SA1.29%$1.52MCHF190.59B15.67%
71
Outperform
Siemens1.25%$1.48M€198.34B29.64%
74
Outperform
Allianz1.19%$1.41M€144.77B27.96%
67
Neutral

GSEU Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
44.31
Positive
100DMA
43.68
Positive
200DMA
41.98
Positive
Market Momentum
MACD
0.61
Negative
RSI
70.53
Negative
STOCH
81.41
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GSEU, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 45.54, equal to the 50-day MA of 44.31, and equal to the 200-day MA of 41.98, indicating a bullish trend. The MACD of 0.61 indicates Negative momentum. The RSI at 70.53 is Negative, neither overbought nor oversold. The STOCH value of 81.41 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GSEU.

GSEU Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$118.14M0.25%
$30.00B0.06%
$9.23B0.50%
$748.93M0.07%
$678.75M0.45%
$119.42M0.09%
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GSEU
Goldman Sachs ActiveBeta Europe Equity ETF
46.36
12.96
38.80%
VGK
Vanguard FTSE Europe ETF
EZU
iShares MSCI Eurozone ETF
SPEU
SPDR Portfolio Europe ETF
DBEU
Xtrackers MSCI Europe Hedged Equity ETF
FLEE
Franklin FTSE Europe ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement